| |
| |
|
| Insider
Information: |
Ajer Jeffrey Robert |
| Relationship: |
Director |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
105,620 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,381,251 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
105,620 |
|
|
| Total
Value |
$6,381,251 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -71.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Commercial ... |
2024-03-15 |
71,467 |
|
0 |
Premium* |
|
|
Nektar Therapeutics |
NKTR |
Director |
2023-09-18 |
34,153 |
2017-09-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2024-03-15 |
4 |
D |
$83.87 |
$1,893,785 |
D/D |
(22,580) |
71,467 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2024-03-05 |
4 |
AS |
$87.07 |
$348,280 |
D/D |
(4,000) |
94,047 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2024-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
37,243 |
98,047 |
0 |
- |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2023-09-18 |
4 |
S |
$0.69 |
$3,008 |
D/D |
(4,359) |
34,153 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2023-08-16 |
4 |
AS |
$90.00 |
$450,000 |
D/D |
(5,000) |
60,804 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2023-04-28 |
4 |
A |
$66.88 |
$21,267 |
D/D |
318 |
65,804 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2023-03-16 |
4 |
D |
$93.41 |
$1,915,839 |
D/D |
(20,510) |
65,486 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2023-03-15 |
4 |
D |
$87.74 |
$348,416 |
D/D |
(3,971) |
85,996 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,110 |
89,967 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2023-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
38,769 |
79,857 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2023-01-25 |
4 |
AS |
$115.65 |
$5,669,134 |
D/D |
(49,000) |
41,088 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2023-01-25 |
4 |
OE |
$67.81 |
$3,322,690 |
D/D |
49,000 |
90,088 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-11-02 |
4 |
AS |
$86.12 |
$258,360 |
D/D |
(3,000) |
41,088 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2022-09-23 |
4 |
S |
$3.16 |
$13,266 |
D/D |
(4,198) |
38,512 |
0 |
% |
|
| NKTR |
Nektar Therapeutics |
Director |
– • – |
2022-09-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,200 |
42,710 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-08-11 |
4 |
AS |
$95.62 |
$286,860 |
D/D |
(3,000) |
44,088 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-06-03 |
4 |
D |
$77.49 |
$544,057 |
D/D |
(7,021) |
47,088 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-05-26 |
4 |
AS |
$78.94 |
$103,254 |
D/D |
(1,308) |
54,109 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-04-29 |
4 |
A |
$62.41 |
$21,218 |
D/D |
340 |
55,417 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-04-13 |
4 |
AS |
$82.47 |
$97,315 |
D/D |
(1,180) |
55,077 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-03-30 |
4 |
AS |
$79.56 |
$109,872 |
D/D |
(1,381) |
56,257 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-03-29 |
4 |
AS |
$79.43 |
$128,518 |
D/D |
(1,618) |
57,638 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-03-23 |
4 |
AS |
$81.78 |
$501,230 |
D/D |
(6,129) |
59,256 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-03-22 |
4 |
AS |
$81.00 |
$167,913 |
D/D |
(2,073) |
65,385 |
0 |
% |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Commercial Officer |
• – – |
2022-03-16 |
4 |
D |
$80.72 |
$103,887 |
D/D |
(1,287) |
67,458 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
